Arcutis Director Sells $121,000 Amid ZORYVE Revenue Surge
A biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
Know when to use hot wallet vs cold wallet based on activity level and risk tolerance. This guide helps you choose wisely for everyday and long-term needs.
17,586 articlesA biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
What could push the aave token could climb in the next decade? This guide breaks down the catalysts, risks, and pract...
The AI boom has put semiconductors in the spotlight. This guide breaks down the AMD vs Intel debate, offering a clear...
delek holdings rallied today captured market attention as a mid-cap refiner with jet-fuel exposure and a strategic st...
Two clinical-stage biotech names, two distinct paths to value. This guide breaks down Dyne Therapeutics and Viking Th...
U.S. regulators have cleared broader access to Anthropic’s Mythos model after a brief regulatory stand-off over safet...
AI is reshaping business, and a few durable names stand to benefit for years. Here are three artificial intelligence ...
SpaceX is redefining its business beyond rocket launches. This article explains the spacex made huge pivot, what it c...
NVIDIA CEO Jensen Huang told investors that AI-powered supercomputing could become a common feature in homes within y...
Sotheby’s hosts its inaugural AI-generated artwork sale, featuring the Ai-Da robot painting a portrait of Alan Turing...
When a public figure shares an Alzheimer’s diagnosis, it shines a light on the real-life finances behind care. This g...
The space economy is expanding, yet investing in it without a plan can blow up portfolios. This guide explains why wa...